Antimicrobial Resistance Dynamics in Urinary Tract Infections
Summary
Antimicrobial resistance in urinary tract infections has emerged as a global health priority. Escherichia coli remains the predominant uropathogen, accounting for around 75–80 % of community-acquired cases, but other species such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis contribute substantially, especially in healthcare-associated settings. The proliferation of extended-spectrum β-lactamase (ESBL)–producing and carbapenemase-producing strains has eroded the efficacy of first-line oral agents, including trimethoprim-sulfamethoxazole and fluoroquinolones. Multidrug resistance, driven by plasmid-mediated gene transfer and clonal expansion (notably E. coli ST131), complicates empirical treatment and fosters recurrent infection, increased hospitalisation and higher healthcare costs. Dynamic surveillance data reveal regional variation in resistance phenotypes, necessitating local antibiograms to guide therapy. Advances in rapid molecular diagnostics have improved detection of polymicrobial and fastidious organisms, but cost and access barriers persist. As a result, antibiotic stewardship, tailored de-escalation strategies and investment in novel diagnostics are paramount to curtail resistance spread, preserve existing agents and optimise patient outcomes.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Antimicrobial Resistance Dynamics in Urinary Tract Infections publication trend
The graph below shows the total number of articles in antimicrobial resistance dynamics in urinary tract infections across all publications each year (not limited to Nature Index journals).
Technical terms
Antimicrobial resistance (AMR): Ability of microorganisms to withstand drugs that would normally kill them or inhibit growth.
Extended-spectrum β-lactamase (ESBL): Enzyme that confers resistance to a broad range of β-lactam antibiotics, including third-generation cephalosporins.
Carbapenemase: Enzyme capable of hydrolysing carbapenem antibiotics, leading to high-level resistance.
Multidrug resistance (MDR): Non-susceptibility to at least one agent in three or more antimicrobial categories.
Polymicrobial infection: Presence of two or more microbial species contributing to the disease process.
Loop-mediated Isothermal Amplification (LAMP): A rapid DNA amplification method performed at constant temperature for pathogen detection.
Empirical therapy: Initiation of treatment based on clinical judgement before specific microbiological data are available.
References
- The Essential Role of PCR and PCR Panel Size in Comparison with Urine Culture in Identification of Polymicrobial and Fastidious Organisms in Patients with Complicated Urinary Tract Infections. International Journal of Molecular Sciences (2023).
- Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019. Antimicrobial Resistance & Infection Control (2024).
- A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP. Journal of Clinical Microbiology (2024).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.